CONMED Corporation
CNMD
$38.46
-$0.95-2.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.18% | 4.61% | 3.94% | 4.32% | 5.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.18% | 4.61% | 3.94% | 4.32% | 5.00% |
| Cost of Revenue | 10.54% | 3.33% | 2.05% | 2.61% | 2.87% |
| Gross Profit | 0.99% | 5.62% | 5.43% | 5.68% | 6.74% |
| SG&A Expenses | 7.09% | 7.20% | 5.79% | 4.68% | 2.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.60% | 4.82% | 3.61% | 3.43% | 2.77% |
| Operating Income | -19.44% | 2.97% | 6.44% | 11.55% | 24.46% |
| Income Before Tax | -56.38% | -46.58% | 11.13% | 39.96% | 101.70% |
| Income Tax Expenses | -21.38% | -24.34% | 8.65% | 23.66% | 86.96% |
| Earnings from Continuing Operations | -64.47% | -51.37% | 11.77% | 44.20% | 105.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.47% | -51.37% | 11.77% | 44.20% | 105.44% |
| EBIT | -19.44% | 2.97% | 6.44% | 11.55% | 24.46% |
| EBITDA | -12.34% | 2.88% | 4.98% | 7.82% | 15.95% |
| EPS Basic | -64.59% | -51.56% | 11.32% | 43.61% | 104.60% |
| Normalized Basic EPS | -21.19% | 7.93% | 12.01% | 18.80% | 37.57% |
| EPS Diluted | -64.38% | -51.31% | 12.39% | 45.55% | 107.80% |
| Normalized Diluted EPS | -20.71% | 8.97% | 13.56% | 21.02% | 40.19% |
| Average Basic Shares Outstanding | 0.38% | 0.48% | 0.49% | 0.51% | 0.57% |
| Average Diluted Shares Outstanding | -0.28% | -0.47% | -0.88% | -1.38% | -1.23% |
| Dividend Per Share | -25.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.83% | 1.07% | -0.10% | -0.30% | -0.51% |